Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-30

FDA Approved: ELETRIPTAN HYDROBROMIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Eletriptan hydrobromide from Mylan Pharmaceuticals Inc., authorizing a generic version for the acute treatment o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eletriptan Hydrobromide (eletriptan hydrobromide)

Snippet

SUPPL AP for ELETRIPTAN HYDROBROMIDE (ELETRIPTAN HYDROBROMIDE)